Welcome to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
Yes
No
NB: We use cookies to help personalise your web experience and comply with Irish healthcare law. Whatever your choice, you are agreeing to our use of cookies. Please close this browser tab if you don't want to proceed.
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

June 27, 2016

Marked reduction in PSA testing

A US Task Force recommendation against PSA-based screening had a major effect, Gary Culliton heard at the John Fitzpatrick Irish Prostate Cancer Conference. Since this policy decision was made, there has been a considerable impact on rates of detection

HCV: On the road to global elimination

In one of the greatest success stories of medicine, the elimination of hepatitis C is now firmly in sight, RCSI alumnus and Harvard’s Prof Nezam Afdhal tells Irish Medical Times in an interview with Lloyd Mudiwa

Prevention of COPD exacerbations

In a ‘Focus on COPD’, Caroline McDermott, Editor of MIMS Ireland, examines how to prevent acute exacerbations of the disease, but also when hospital admission may be required for COPD patients

Going green on female contraception

Medical writer Tim Pearson attended the 14th Congress of the European Society for Contraception and Reproductive Health in Basel, Switzerland last month, to hear some of the current hot topics in the field, including developments in LARCs and on the concept of ‘green contraception’

Asthma control and management

In a ‘Focus on Asthma’, Caroline McDermott, Editor of MIMS Ireland, examines the importance of having a personalised asthma management plan in place so that the condition can be optimally managed and controlled

High-priced drugs for DMO questioned

The anti-vascular endothelial growth factor drugs ranibizumab and aflibercept, used to treat vision loss from diabetic macular oedema (DMO), and approximately 20 to 30 times more expensive than bevacizumab, are not cost-effective for treatment of DMO compared to bevacizumab, unless their prices decrease substantially, according to a study published online by JAMA Ophthalmology

Whole grain lowers risk of chronic diseases

A higher intake of whole grain foods is associated with reduced risk of major chronic conditions, such as cardiovascular disease and cancer, as well as lower risk of death from a range of diseases, show findings published by The BMJ.

Prompt use of biological for RA is recommended

Prompt and intensive use of the biological tocilizumab in the treatment of patients who have recently been diagnosed with rheumatoid arthritis (RA) is more effective than the standard methotrexate treatment

Screening for syphilis a benefit for those at risk

The US Preventive Services Task Force (USPSTF) has found convincing evidence that screening for syphilis infection in asymptomatic, non-pregnant persons at increased risk of infection provides substantial benefit

Most antidepressants ineffective for children and teens

Most available antidepressants are ineffective, and some may be unsafe, for children and teenagers with major depression, according to the most comprehensive comparison of commonly prescribed antidepressant drugs so far, published in The Lancet.

Next Page »